Growing community of inventors

Dijon, France

David Vandroux

Average Co-Inventor Count = 3.20

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 8

David VandrouxEmmanuel De Maistre (4 patents)David VandrouxEdouard Prost (2 patents)David VandrouxFrancois Coutard (1 patent)David VandrouxLaure Dumont (1 patent)David VandrouxLaure Dumont Di Leone (1 patent)David VandrouxFrançois Coutard (0 patent)David VandrouxEdourd Prost (0 patent)David VandrouxDavid Vandroux (4 patents)Emmanuel De MaistreEmmanuel De Maistre (4 patents)Edouard ProstEdouard Prost (2 patents)Francois CoutardFrancois Coutard (4 patents)Laure DumontLaure Dumont (1 patent)Laure Dumont Di LeoneLaure Dumont Di Leone (1 patent)François CoutardFrançois Coutard (0 patent)Edourd ProstEdourd Prost (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Centre Hospitalier Universitaire De Dijon (3 from 4 patents)

2. Nvh Medicinal (2 from 2 patents)

3. Other (1 from 832,812 patents)

4. Centre Hospitalier Universitaire De (1 from 1 patent)

5. Vandroux, David (0 patent)


4 patents:

1. 9878018 - Collagen-based injectable preparations capable of controlling bleeding and/or of substituting for platelets in the case of haemorrhagic syndromes

2. 9581603 - Collagen-derived recombinant proteins with von Willebrand factor-binding activity

3. 9115183 - Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation

4. 8557774 - Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/18/2025
Loading…